Skip to Content

TEVA 5346 (Methylphenidate hydrochloride extended-release (LA) 20 mg)

Pill imprint TEVA 5346 has been identified as Methylphenidate hydrochloride extended-release (LA) 20 mg.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression; obesity; fatigue (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Methylphenidate hydrochloride extended-release (LA) 20 mg TEVA 5346
Discount Card Promo
Methylphenidate hydrochloride extended-release (LA)
TEVA 5346
20 mg
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Teva Pharmaceuticals USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.